Clinical trials
Lower Urinary Tract Symptoms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 3 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Not yet recruiting | 6 |
| Unknown status | 4 |
| Recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 3 |
| Changhai Hospital | 2 |
| Shanghai Huilun Pharmaceutical Co., Ltd. | 2 |
| Anhui Medical University | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| First Affiliated Hospital, Sun Yat-Sen University | 1 |
| Fudan University | 1 |
| Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 1 |
| Peking University First Hospital | 1 |
| Qilu Hospital of Shandong University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lower Urinary Tract Symptoms | 19 |
| Prostatic Hyperplasia | 11 |
| Renal Insufficiency, Chronic | 2 |
| Urinary Retention | 2 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus | 1 |
| Dysuria | 1 |
| Essential Hypertension | 1 |
| Hypertension | 1 |
| Metabolic Syndrome | 1 |
Trials
Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.